4-Azaindole - CAS 272-49-1
Catalog: |
BB019508 |
Product Name: |
4-Azaindole |
CAS: |
272-49-1 |
Synonyms: |
1H-pyrrolo[3,2-b]pyridine; 1H-pyrrolo[3,2-b]pyridine |
IUPAC Name: | 1H-pyrrolo[3,2-b]pyridine |
Description: | 4-Azaindole (CAS# 272-49-1) is a useful research chemical. |
Molecular Weight: | 118.14 |
Molecular Formula: | C7H6N2 |
Canonical SMILES: | C1=CC2=C(C=CN2)N=C1 |
InChI: | InChI=1S/C7H6N2/c1-2-6-7(8-4-1)3-5-9-6/h1-5,9H |
InChI Key: | XWIYUCRMWCHYJR-UHFFFAOYSA-N |
Boiling Point: | 273.8 °C |
Density: | 1.242 g/cm3 |
MDL: | MFCD00971977 |
LogP: | 1.56290 |
GHS Hazard Statement: | H302 (25%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113200983-A | Compound with pyrrolopyridine structure, preparation method and medical application | 20210522 |
CN-113292561-A | Compound with dipyrrolopyridine structure, preparation method and medical application | 20210522 |
CN-112794851-A | 3- (pyridine-3-yl) -7-azaindole derivative PI3K delta inhibitor and preparation method and application thereof | 20210126 |
CN-113214247-A | Azaindole derivative marrow cell proliferation inhibitor, preparation method and application thereof in pharmacy | 20210114 |
CN-112300176-A | Method for synthesizing chiral five-membered thiaheterocyclic nucleoside analogue by asymmetric [3+2] cyclization reaction | 20201127 |
PMID | Publication Date | Title | Journal |
23200254 | 20130101 | Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores | Bioorganic & medicinal chemistry letters |
22925984 | 20121101 | Spectroscopic study of the ground and excited state prototropic equilibria of 4-azaindole | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
22643974 | 20121001 | Some insights into the binding mechanism of Aurora B kinase gained by molecular dynamics simulation | Journal of molecular modeling |
23125772 | 20121001 | N-[(3RS,4SR)-1-Benzyl-4-methyl-piperi-din-3-yl]-1-(4-methylphenyl-sulfonyl)-5-nitro-1H-pyrrolo-[2,3-b]pyridin-4-amine | Acta crystallographica. Section E, Structure reports online |
23125813 | 20121001 | N-[(3RS,4RS)-1-Benzyl-4-methyl-piperidin-3-yl]-5-nitro-1-phenyl-sulfonyl-1H-pyrrolo-[2,3-b]pyridine-4-amine | Acta crystallographica. Section E, Structure reports online |
Complexity: | 103 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 118.053098200 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 118.053098200 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Azaindoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS